期刊文献+

Podoplanin和CD34在宫颈癌中的表达及其意义

Expression of Podoplanin and CD34 In invasive carcinoma of cervix
下载PDF
导出
摘要 目的:研究Podoplanin、CD34在宫颈癌中的表达及其意义。方法:用免疫组化方法检测53例早期宫颈癌ICC和15例癌旁正常宫颈上皮(NEC)中Podoplanin和CD34表达情况。结果:宫颈癌组织中Podoplanin和CD34阳性表达率分别为90.5%、100%。Podoplanin在宫颈癌旁正常宫颈组织未发现阳性表达。宫颈癌组织Podoplanin和CD34表达呈正相关。(χ2=23.432,P<0.05),二者的联合表达与淋巴结转移及预后密切相关(P<0.05)。结论:Podoplanin和CD34可能在宫颈癌的发生发展过程中起关键作用,二者在肿瘤转移过程中密切相关。检测其表达水平,对于宫颈癌的诊断、恶性程度及预后的判断有一定价值。 Objective To investigate the expressions of Podoplanin and CD34 in invasive carcinoma of cervix and explore their relationship to clinical biological behavior.Method Expression of Podoplanin and CD34 in 53 cases of early invasive carcinoma of cervix and 15 cases of normal cervical epithelium remote from tumor were detected by immunohistochemistry SP method during Jan 1996 to Dec 1998.Results 1.The positive expression rate of Podoplanin and CD34 in early invasive carcinoma of cervix was 90.5 % and 100% respectively.No expression of Podoplanin was detected in normal cervical epithelium(NEC) remote from tumor.2.In ICC Podoplanin was positively related to expression of CD34(χ2=23.432,P0.05).Associated expression of Podoplanin and CD34 was closely correlated to lymph node metastasis and prognosis(P0.05).Conclusion Podoplanin and CD34 may play a pivotal role in tumor genesis and tumor progression in cervical carcinoma and they have intimate relation in tumor metastasis.Detection of their expression may be valuable for diagnosing cervical carcinoma,degree of malignancy and prognosis.
出处 《吉林医学》 CAS 2013年第19期3757-3759,共3页 Jilin Medical Journal
关键词 宫颈癌 PODOPLANIN CD34 免疫组织化学 Cervical neoplasms Podoplanin CD34 Immunohistochemistry
  • 相关文献

参考文献8

二级参考文献79

  • 1[1]Ferrara N, Hetzel WJ. Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Comm, 1989; 161: 851~8
  • 2[2]Forkman J. Antiangiogenic gene therapy. Proc Natl Acad Sci USA, 1998; 95: 9064~6
  • 3[3]Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature (Lond), 2000; 407: 249~57
  • 4[4]Plate KH. From angiogenesis to lymphangiogenesis. Nature Med, 2001; 7: 151~3
  • 5[5]Niki T, Iba S, Tokunou M et al. Expression of vascular endothelial growth factor A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res, 2000; 6: 2431~9
  • 6[6]Akaji K, Ikeda Y, Miyazaki M et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer, 2000; 83: 887~91
  • 7[7]Kim KJ. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature, 1993; 362: 841~4
  • 8[8]Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis? Cell, 1996; 87: 1153~5
  • 9[9]Neufeld G, Cohen T, Gengrinovitch S et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J, 1999; 13: 9~22
  • 10[10]Skobe M, Hawighorst T, Jackson DG et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nature Med, 2001; 7: 192~8

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部